Trump said he doesn't see a recession after the bond market spooked investors and the Dow suffered its worst day of the year last week.Marketsread more
The U.K. prime minister prepares to meet his German and French counterparts this week.Europe Politicsread more
Amazon is raising seller fees for thousands of small and medium-sized businesses in France because of a new digital tax passed by the French government.Technologyread more
U.S. stock index futures point to a higher open on Monday morning as the White House sought to calm investors over growing concerns about the U.S. economy.US Marketsread more
Ahead of the deadline, U.S. President Donald Trump told reporters that Huawei was a national security threat.Technologyread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
Baidu is gearing up to release its second-quarter earnings on Monday with the market expecting a sharp decline in profit.Technologyread more
Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Stocks in Asia rose on Monday as U.S. Treasury yields bounced higher after plunging last week.Asia Marketsread more
The problem with tanking equities lies elsewhere, writes Michael Ivanovitch, because traders see no end to America's unfolding trade disputes with Europe and China.World Economyread more
Beijing wants to use reforms to support a slowing economy.China Marketsread more
Hurry up and keep on waiting.
The U.S. Supreme Court early Monday kept mum on a request that it consider a case that threatens to cripple Obamacare and end financial assistance to more than 4 million HealthCare.gov customers.
The high court's decision, or lack thereof, was being closely watched by Obamacare advocates, opponents, and the White House because of the risk the case poses to the Affordable Care Act.
Less than two hours after it didn't take action in the case, the Supreme Court relisted it for consideration at Friday's weekly conference of the court's justices. That means a vote on whether to take up the case would likely occur that day, although the decision would not be announced until Nov. 10.
The court may opt to delay taking the case until several federal appeals courts finish considering the key issue.
"I don't think it means anything yet other than, 'I'm going to have to agonize for a week,'" said Timothy Jost, an Obamacare expert and professor at Washington & Lee University School of Law.
The King case, as well as the three other essentially identical court challenges, claim federal subsidies that help most customers pay for health insurance premiums on HealthCare.gov are illegal under the ACA.
HealthCare.gov, which is operated by the federal government, sells private individual insurance plans in 36 states. Open enrollment on that exchange, and on the marketplaces operated by individual states, resumes Nov. 15. For now, the subsidies on HealthCare.gov remain available.
The legal challenge to the subsidies, if successful, would end the taxpayer-funded assistance that helps HealthCare.gov customers afford their health coverage. It would also destroy, in states served by HealthCare.gov, the Obamacare rule that starting in 2015 requires mid- to large-sized employers to offer affordable health plans to workers or face fines.
And a successful challenge also would effectively gut in those states the mandate that requires most people to have some form of insurance or pay a tax penalty.
Both the so-called employer and individual mandates are technically hinged on the existence of the subsidies.
Obamacare opponents and advocates, who rarely agree, have said the court challenge represents the biggest threat to the ACA since the 2012 Supreme Court decision that upheld much of the law.
Plaintiffs in the past several years have filed four separate federal lawsuits challenging the legality of the subsidies.
All four suits point to explicit language in the ACA.
The act authorizes subsidies for enrollees of a state-run health-care exchange. It does not specifically say such subsidies can be issued to enrollees on the federally run exchange HealthCare.gov.
Obamacare advocates long scoffed at that argument and were dismissive of speculation that the court cases would go anywhere.
Those advocates also pointed to other language in the ACA that considered the need for a federal exchange if states didn't set up their own insurance marketplaces. They argued it would be absurd, given the law's goal of covering the uninsured, to assume it didn't intend to offer federal exchange enrollees the same help buying coverage that state exchange enrollees received.
But on a single day in July, a three-judge panel in Washington, D.C.'s federal appeals court ruled 2-1 that the subsidies were illegal, while a Virginia federal appellate panel ruled 3-0 that they are legal.
The split boosted chances that Supreme Court would step in.
But in September, the entire D.C. appeals court said it would reconsider its decision. The Obama administration is considered to have the edge with that circuit because a majority of the judges were appointed by Democratic presidents.
The plaintiffs who lost the challenge in the Virginia federal appeals court did not ask for a rehearing from the full circuit, but instead went directly to the Supreme Court. There is no automatic right to a hearing by the Supreme Court.